| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.05B | 58.27B | 47.41B | 82.33B | 78.95B | 49.62B |
| Gross Profit | 6.06B | 5.65B | 4.90B | 8.35B | 9.00B | 4.63B |
| EBITDA | 3.79B | 3.65B | 4.01B | 7.77B | 7.67B | 4.04B |
| Net Income | 1.35B | 1.54B | 804.03M | 3.58B | 5.75B | 2.90B |
Balance Sheet | ||||||
| Total Assets | 43.28B | 42.70B | 42.12B | 45.33B | 48.16B | 56.90B |
| Cash, Cash Equivalents and Short-Term Investments | 6.09B | 6.58B | 6.52B | 9.29B | 9.91B | 8.95B |
| Total Debt | 11.56B | 11.49B | 10.86B | 11.76B | 10.10B | 13.66B |
| Total Liabilities | 23.79B | 23.62B | 22.01B | 24.08B | 23.33B | 24.42B |
| Stockholders Equity | 17.01B | 16.76B | 17.59B | 18.43B | 21.04B | 27.48B |
Cash Flow | ||||||
| Free Cash Flow | 2.68B | 2.16B | 2.13B | 3.94B | 4.19B | 3.26B |
| Operating Cash Flow | 3.39B | 2.87B | 2.95B | 5.56B | 5.93B | 4.56B |
| Investing Cash Flow | -1.17B | -777.19M | -1.75B | -574.03M | 10.80B | -329.22M |
| Financing Cash Flow | -2.24B | -2.13B | -3.69B | -4.15B | -15.65B | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$143.01B | 11.17 | 14.02% | 3.05% | 12.64% | 2.90% | |
73 Outperform | HK$94.22B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
64 Neutral | HK$46.98B | 11.39 | 9.46% | 6.39% | -17.69% | -3.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$12.00B | 5.27 | 8.00% | 3.55% | 26.36% | -18.67% | |
62 Neutral | HK$2.38B | 17.02 | 9.22% | 8.25% | 56.58% | 1963.38% | |
61 Neutral | HK$91.56B | 24.42 | 5.53% | ― | 12.14% | ― |